Moolec Science (MLEC) Change in Receivables (2022 - 2024)
Moolec Science (MLEC) reported Change in Receivables of -$1.4 million for Q4 2024, down 1494.85% on a YoY basis from $98131.0 in Q1 2024, and down 2257.48% sequentially from -$58061.0 in Q3 2024.
Moolec Science (MLEC) Change in Receivables (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Change in Receivables data on file, last reported at -$1.4 million in Q4 2024.
- For the quarter ending Q4 2024, Change in Receivables fell 1494.85% year-over-year to -$1.4 million; the trailing twelve-month figure through Dec 2024 stood at -$7.7 million (changed N/A YoY), and the FY2025 full-year result was $26.0 million, up 510.85% from the prior year.
- Change in Receivables eased to -$1.4 million in Q4 2024, from -$58061.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $98131.0 in Q4 2023 to a low of -$6.1 million in Q2 2024.
- A 3-year average of -$1.1 million and a median of -$146394.0 in 2023 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 60.34% in 2024, while the deepest fall reached 1494.85% in 2024.
- Tracing MLEC's Change in Receivables over 3 years: stood at $172.0 in 2022, then jumped by 56952.91% to $98131.0 in 2023, then sank by 1494.85% to -$1.4 million in 2024.
- Business Quant data shows MLEC's Change in Receivables at -$1.4 million in Q4 2024, -$58061.0 in Q3 2024, and -$6.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.37 Mn |
| Dec 31, 2024 | -1.37 Mn |
| Sep 30, 2024 | -58,061.00 |
| Sep 30, 2024 | -58,061.00 |
| Jun 30, 2024 | -6.13 Mn |
| Jun 30, 2024 | -6.13 Mn |
| Mar 31, 2024 | -162,073.00 |
| Mar 31, 2024 | -162,073.00 |
| Dec 31, 2023 | 98,131.00 |
| Dec 31, 2023 | 98,131.00 |
| Sep 30, 2023 | -146,394.00 |
| Sep 30, 2023 | -146,394.00 |
| Mar 31, 2022 | 172.00 |
| Mar 31, 2022 | 172.00 |